[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

DelveInsight: Market Research Reports

DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:

  • Company’s profile and licensing data;
  • New technology studies;
  • Biologic benchmarking;
  • Treatment modality analysis;
  • Competitive landscape;
  • Product assessment; etc.


This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.

DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.

Publications found: 6,889
Sort by:

Chronic Heart Failure - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Chronic Heart Failure Key assessments Patient Segmentation in Chronic Heart Failure Chronic Heart Failure Risk & Burden Factors driving growth in a specific Chronic Heart Failure patient population

January 2022 60 pages

Cialis - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Cialis API intelligence over Cialis and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Colcrys - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Colcrys API intelligence over Colcrys and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Combivir - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Combivir API intelligence over Combivir and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Concerta - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Concerta API intelligence over Concerta and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Copaxone - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Copaxone API intelligence over Copaxone and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Diprivan EML - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Diprivan EML API intelligence over Diprivan EML and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Efient - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Efient API intelligence over Efient and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Erectile Dysfunction - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Erectile Dysfunction Key assessments Patient Segmentation in Erectile Dysfunction Erectile Dysfunction Risk & Burden Factors driving growth in a specific Erectile Dysfunction patient population

January 2022 60 pages

Esophageal Cancer - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Esophageal Cancer Key assessments Patient Segmentation in Esophageal Cancer Esophageal Cancer Risk & Burden Factors driving growth in a specific Esophageal Cancer patient population

January 2022 60 pages

Eviplera - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Eviplera API intelligence over Eviplera and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Exjade - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Exjade API intelligence over Exjade and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Fabry Disease - Epidemiology Forecast to 2032

US$ 3,950.00

... epidemiology historical and forecasted data of Fabry Disease prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease ... Fabry Disease market. Identifying prevalent patient populations as well as risk factors in the global Fabry Disease ...

January 2022 60 pages

Fampyra - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Fampyra API intelligence over Fampyra and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Fosamax - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Fosamax API intelligence over Fosamax and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Fumarate De Formoterol - API Insight, 2022

US$ 500.00

... advantage by identifying the key patent expiry details with respect to Fumarate De Formoterol API intelligence over Fumarate De Formoterol and gaining primary intelligence over Active Ingredient manufacturers by country Make more ...

January 2022 30 pages

Fusilev - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Fusilev API intelligence over Fusilev and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Gasmotin - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Gasmotin API intelligence over Gasmotin and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Gaster D - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Gaster D API intelligence over Gaster D and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Gemzar - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Gemzar API intelligence over Gemzar and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Geninax - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Geninax API intelligence over Geninax and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Graceptor - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Graceptor API intelligence over Graceptor and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Hereditary Angioedema - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

... 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Hereditary Angioedema Report Assessment Current Treatment Practices in Hereditary Angioedema Unmet Needs in Hereditary Angioedema Market Attractiveness Market Drivers and Barriers KEY BENEFITS The ...

January 2022 200 pages

Imitrex - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Imitrex API intelligence over Imitrex and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Imprida - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Imprida API intelligence over Imprida and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Imusera - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Imusera API intelligence over Imusera and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Integrilin - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Integrilin API intelligence over Integrilin and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Intuniv - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Intuniv API intelligence over Intuniv and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Invanz - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Invanz API intelligence over Invanz and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Invega Sustenna/Xeplion - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Invega Sustenna/Xeplion API intelligence over Invega Sustenna/Xeplion and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Iressa - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Iressa API intelligence over Iressa and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Isentress - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Isentress API intelligence over Isentress and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Jalyn - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Jalyn API intelligence over Jalyn and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Jevtana Kit - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Jevtana Kit API intelligence over Jevtana Kit and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Kaletra - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Kaletra API intelligence over Kaletra and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Keppra - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Keppra API intelligence over Keppra and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Kivexa - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Kivexa API intelligence over Kivexa and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Lamictal - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Lamictal API intelligence over Lamictal and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Latuda - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Latuda API intelligence over Latuda and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Loestrin 24 Fe - API Insight, 2022

US$ 500.00

... highlighted API manufacturers for Loestrin 24 Fe in United States, Europe, China and India The report contains historical and forecasted sales for Loestrin 24 Fe till 2021 Enlists the market ...

January 2022 30 pages

Lovenox With Preservative - API Insight, 2022

US$ 500.00

... advantage by identifying the key patent expiry details with respect to Lovenox With Preservative API intelligence over Lovenox With Preservative and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed ...

January 2022 30 pages

Lumigan RC - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Lumigan RC API intelligence over Lumigan RC and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Lunesta - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Lunesta API intelligence over Lunesta and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Lyrica - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Lyrica API intelligence over Lyrica and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Maxalt - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Maxalt API intelligence over Maxalt and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Metgluco - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Metgluco API intelligence over Metgluco and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Methycobal Tablets - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Methycobal Tablets API intelligence over Methycobal Tablets and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Mezavant Xl - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Mezavant Xl API intelligence over Mezavant Xl and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Mucodyne - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Mucodyne API intelligence over Mucodyne and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Mucosta - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Mucosta API intelligence over Mucosta and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Filters

Search

Categories

5,477
618
651
143

Publishers

6,889

Regions

6,889

Price

Date

Pages

Offers